|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit/(loss) for the year | |||||
| Adjustments: | |||||
| Depreciation and amortization | |||||
| Financing expenses, net | |||||
| Share in profit of OPC's equity-accounted investees, net | |||||
| Losses related to Qoros | |||||
| (Gain)/loss for the year from divestment of ZIM | |||||
| Gain on loss of control in the CPV Renewable | |||||
| Share-based payments | |||||
| Other expenses, net | |||||
| Income taxes | |||||
| Total adjustments | |||||
| Change in trade and other receivables | |||||
| Change in trade and other payables | |||||
| Cash generated from operating activities | |||||
| Dividends received from associated companies, net | |||||
| - ZIM | |||||
| - OPC’s equity-accounted investees | |||||
| Total dividends received from associated companies, net | |||||
| Income taxes paid, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Short-term deposits and restricted cash, net | |||||
| Short-term collaterals deposits, net | |||||
| Investment in long-term deposits, net | |||||
| Investments in equity-accounted investees, less cash acquired | |||||
| Acquisition of subsidiary, less cash acquired | |||||
| Acquisition of property, plant and equipment, intangible assets and payment of long-term advance deposits and prepaid expenses | |||||
| Proceeds from sales of interest in ZIM | |||||
| Proceeds from gain on loss of control in the CPV Renewable | |||||
| Proceeds from distribution from equity-accounted investees | |||||
| Proceeds from sale of subsidiary, net of cash disposed off | |||||
| Proceeds From Sale Of Subsidiary Without Loss Of Control | |||||
| Proceeds from sale of other investments | |||||
| Purchase of other investments | |||||
| Long-term loan to an associate | |||||
| Reimbursement in respect of right-of-use asset | |||||
| Interest received | |||||
| Payment of financial guarantee | |||||
| Proceeds from transactions in derivatives, net | |||||
| Net cash (used in)/provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Repayment of long-term loans, debentures and lease liabilities | |||||
| Proceeds from/(repayment of) short-term credit from banks and others, net | |||||
| Proceeds from Veridis transaction | |||||
| Proceeds from issuance of share capital by a subsidiary to non-controlling interests, net of issuance expenses | |||||
| Investments from holders of non-controlling interests in equity of subsidiary | |||||
| Tax Equity Investment | |||||
| Receipt of long-term loans, net | |||||
| Proceeds from derivative financial instruments, net | |||||
| Repurchase of own shares | |||||
| Costs paid in advance in respect of taking out of loans | |||||
| Cash distribution and dividends paid | |||||
| Dividends paid to holders of non-controlling interests | |||||
| Payment of early redemption commission with respect to the debentures | |||||
| Proceeds from issuance of debentures, less issuance expenses | |||||
| Interest paid | |||||
| Net cash provided by/(used in) financing activities | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Effect of exchange rate fluctuations on balances of cash and cash equivalents | |||||
| Cash and cash equivalents at end of the year | |||||
Loading...